Michael Blaha MD, MPHAssociate Professor and Director of Clinical Research, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University Medical Center, Baltimore, Maryland
Dr. Michael J. Blaha (Associate Professor) presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease. He is an Associate Editor for the journals Atherosclerosis and Journal of Cardiovascular Computed Tomography, Associate Editor for the Diabetes and Cardiometabolic Clinical Community on acc.org, and is a standing member of the Endocrinologic and Metabolic Drug Advisory Committee (EMDAC) for the FDA. He has participated in Advisory Boards for many leading pharmaceutical companies in the cardiometabolic space. He serves on both the Statistics Committee and the Early Career Committee for the American Heart Association (AHA), as well as the Publications and Presentations Committee for the Multi-Ethnic Study of Atherosclerosis (MESA). He is co-chair of the Cross Cohort Collaboration (CCC), which seeks to combine data from all ongoing prospective epidemiologic cohorts.
In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 20 trainees and has delivered Grand Rounds lectures at over 10 institutions.
He has received multiple grant awards from the National Institutes of Health, Food and Drug Administration, American Heart Association, Amgen, and the Aetna Foundation.
Dr. Blaha is a founding member of The FIT Project, is a Principal Investigator of the Coronary Artery Calcium Consortium, and is co-director of the mobile health mActive Program at Johns Hopkins.
Clinically, he practices as a preventive non-invasive cardiologist and in the interpretation of cardiac CT.
Recent Contributions to PracticeUpdate:
- Prevalence, Determinants, and Prognostic Value of High CACS in Asymptomatic Patients With Diabetes
- The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes
- Coronary Artery Calcification Is Strongly Associated With CAD Events in Type 1 Diabetes
- The 10-Year Association of Coronary Artery Calcium With Atherosclerotic Cardiovascular Disease